Publications by authors named "Adrian Schmidt"

Claim this Profile
O
Outcomes of patients with suspected heparin-induced thrombocytopenia in a contemporary multicenter cohort.
Henning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adrian Schmidt

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland.
Martina Bertschinger, Holger W Auner, Veronika Ballova, Carmen De Ramon Ortiz, Christoph Driessen, Adrian Schmidt

Swiss Med Wkly· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network.
Max J Rieger, Andreas J Flammer, Sabine Gerull, Thomas Pabst, Holger W Auner, Adrian Schmidt

Swiss Med Wkly· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dynamic range of immunoassays for heparin-induced thrombocytopenia.
Henning Nilius, Samra Naas, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adrian Schmidt

J Thromb Haemost· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literature.
Ramona Meier-Lienhard, Cosima Suter, Thomas Pabst, Felicitas Hitz, Jakob R Passweg, Adrian Schmidt

Swiss Med Wkly· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Detection and Control of Correlated Charge Tunneling in a Quantum Dot.
Johannes C Bayer, Fredrik Brange, Adrian Schmidt, Timo Wagner, Eddy P Rugeramigabo

Phys Rev Lett· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.
Henning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, Jan-Dirk Studt, Dimitrios A Tsakiris, Adrian Schmidt

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Diagnosing Heparin-Induced Thrombocytopenia.
Emil List Larsen, Henning Nilius, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adrian Schmidt

JAMA Netw Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study.
Angelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adrian Schmidt

J Thromb Haemost· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones.
Alicia Rovó, Mathilde Gavillet, Beatrice Drexler, Peter Keller, Jenny Sarah Schneider, Adrian Schmidt

Front Med (Lausanne)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator.
Annika Burger, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Adrian Schmidt

Diagnostics (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
Felicitas Hitz, Noémie Lang, Ulrich Mey, Walter Mingrone, Alden Moccia, Adrian Schmidt

Oncology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study.
Henning Nilius, Adam Cuker, Sigve Haug, Christos Nakas, Jan-Dirk Studt, Adrian Schmidt

EClinicalMedicine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia.
Nathan Cantoni, Roberto Sommavilla, Patrick Seitz, Elisabeth Kulenkampff, Stefan Kahn, Adrian Schmidt

BMC Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q).
Axel Rüfer, Hubert Angermann, Rudolf Benz, Nicolas Bonadies, Antonello Calderoni, Adrian Schmidt

Hemasphere· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study.
Vepusha Sathanantham, Lorenzo Alberio, Cédric Bovet, Pierre Fontana, Bernhard Gerber, Adrian Schmidt

Life (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.
Tamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Adrian Schmidt

Front Cardiovasc Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of transthyretin amyloidosis.
Adalgisa Condoluci, Marie Théaudin, Rahel Schwotzer, Aju P Pazhenkottil, Paolo Arosio, Adrian Schmidt

Swiss Med Wkly· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements.
Tamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Adrian Schmidt

Front Cardiovasc Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal Manifestation of an Epstein-Barr Virus-Associated Plasma Cell Neoplasm.
Eda Arslan, Vita Louisa Sophie Dingerkus, Florian Moritz Heussen, Adrian Schmidt, Kathrin Zaugg

Ocul Oncol Pathol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description of Hb Évora (: c.106T>C) on an Unexpected Allele in a Swiss Family.
Rahel Truttmann, Adrian Schmidt, Britta Hartmann, Sebastian Rusch, Adriana Mendez

Hemoglobin· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation.
Guido Willekens, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Adrian Schmidt

Br J Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.
Ioannis Chanias, Kristina Stojkov, Gregor Th Stehle, Michael Daskalakis, Helena Simeunovic, Adrian Schmidt

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled emission time statistics of a dynamic single-electron transistor.
Fredrik Brange, Adrian Schmidt, Johannes C Bayer, Timo Wagner, Christian Flindt

Sci Adv· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement.
Ioannis Chanias, C Matthias Wilk, Rudolf Benz, Michael Daskalakis, Georg Stüssi, Adrian Schmidt

Int J Environ Res Public Health· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis